Pharmacytimes: Condition Center: Pain Management http://www.pharmacytimes.com/condition-resources/pain/condition-rss Pain Management en-us Mon, 25 Jun 2018 02:06:17 UTC Mon, 25 Jun 2018 02:06:17 UTC Despite Increased Access, Naloxone Prescription Rates Low in Study http://www.pharmacytimes.com/resource-centers/pain/despite-increased-access-naloxone-prescription-rates-low-in-study Researchers were not able to predict factors that would indicate that pharmacists actually dispense the medication.<br /> &nbsp; 3:22 PM, Tue June 19, 2018 Are Nutraceuticals the Answer for Patients with Chronic Conditions? http://www.pharmacytimes.com/resource-centers/pain/are-nutraceuticals-the-answer-for-patients-with-chronic-conditions During a presentation at the American Pharmacy Purchasing Alliance&#39;s Pharmacon in Orlando, FL, several panelists discussed the use of nutraceuticals in managing conditions like chronic pain. 8:20 PM, Sat June 9, 2018 Glove and Stocking Pain: Hallmark of Peripheral Neuropathy http://www.pharmacytimes.com/resource-centers/diabetes/glove-and-stocking-pain-hallmark-of-peripheral-neuropathy Half of people who have diabetes eventually develop diabetic peripheral neuropathy, and the warning signs are sensory symptoms that start in the distant periphery and progressing in a characteristic &#39;glove and stocking&#39; way. 12:25 PM, Thu June 7, 2018 FDA Officials Issue Warning Letters to 3 Kratom Marketers http://www.pharmacytimes.com/news/fda-officials-issue-warning-letters-to-3-kratom-marketers Health care professionals and consumers are encouraged to report any adverse events related to these products to the FDA&rsquo;s&nbsp;MedWatch&nbsp;Adverse Event Reporting program. 9:55 PM, Tue May 22, 2018 FDA Approves Preventive Migraine Treatment http://www.pharmacytimes.com/news/fda-approves-preventive-migraine-treatment Erenumab-aooe (Aimovig, Amgen) is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of the molecule that is involved in migraine attacks. 6:00 PM, Thu May 17, 2018 FDA Approves First Non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults http://www.pharmacytimes.com/news/fda-approves-first-nonopioid-treatment-for-management-of-opioid-withdrawal-symptoms-in-adults The FDA has approved lofexidine hydrochloride (Lucemyra) for the mitigation of opioid withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults. 5:57 PM, Wed May 16, 2018 Neuropathic Pain: A Glimpse Inside the Unabating Affliction http://www.pharmacytimes.com/publications/health-system-edition/2018/March2018/neuropathic-pain-a-glimpse-inside-the-unabating-affliction Originating from damage within nerve cells themselves, neuropathic pain is often complex, with many treatment challenges. 9:00 AM, Tue March 20, 2018 Best Practices in Transforming Chronic Pain Care http://www.pharmacytimes.com/resource-centers/pain/best-practices-in-transforming-chronic-pain-care The number of opioids prescribed in the Untied States was approximately 3 times as high in 2015 as it was in 1999. 12:00 PM, Sun March 11, 2018 FDA OKs Non-Opioid Pain Patch for Post-Herpetic Neuralgia http://www.pharmacytimes.com/product-news/fda-oks-nonopioid-pain-patch-for-postherpetic-neuralgia The FDA approved ZTlido (lidocaine topical system) 1.8% for the treatment of pain associated with post-herpetic neuralgia (PHA), which is caused by shingles. 4:37 PM, Wed February 28, 2018 FDA Approves Short-Term Acute Pain Management Drug http://www.pharmacytimes.com/product-news/fda-approves-shortterm-acute-pain-management-drug Kempharma introduces newly approved pain management drug and warns of risk for addiction. 8:00 AM, Sat February 24, 2018 Surgeons Play Key Role in Reducing Post-Surgery Opioid Dependency http://www.pharmacytimes.com/resource-centers/pain/surgeons-play-key-role-in-reducing-postsurgery-opioid-dependency One in 7 patients who have had lung surgery become persistent opioid users, data note.<br /> <br /> &nbsp; 11:20 AM, Wed February 7, 2018 Opinion: A Reaction to DEA's Efforts to Target Pharmacies with 'Unusual' Opioid Prescription Rates http://www.pharmacytimes.com/contributor/jeffrey-fudin/2018/02/opinion-a-reaction-to-deas-efforts-to-target-pharmacies-with-unusual-opioid-prescription-rates Although it is unclear what constitutes “unusual or disproportionate,” such phrases are particularly disturbing when we realize that the regulation of medical practice is a traditional state function, not a federal one. 2:56 AM, Mon February 5, 2018 The Benefits of Integrating Pharmacists into Surgical Patient Education http://www.pharmacytimes.com/contributor/erik-hefti-pharmd-ms/2018/01/the-benefits-of-integrating-pharmacists-into-surgical-patient-education Surgical patients can exhibit anxiety about the medications they will be started on following surgery. Pharmacists are in a position to address those concerns to the benefit of all. 9:00 AM, Wed January 31, 2018 Migraine Headache: A Look at Current Treatments and the Pipeline http://www.pharmacytimes.com/contributor/ryan-chandanais-ms-cpht/2018/01/migraine-headache-a-look-at-current-treatments-and-the-pipeline Migraine is a condition characterized mainly by severe and recurrent headaches. Approximately 12% of the general population experiences migraines, with a higher frequency in women than men. 1:00 PM, Tue January 30, 2018 Pharmacists' Role in the Management of Perioperative Analgesia http://www.pharmacytimes.com/publications/health-system-edition/2018/january2018/pharmacists-role-in-the-management-of-perioperative-analgesia More than 75% of patients who undergo surgery experience moderate to severe acute postoperative pain that begins immediately following surgery and may extend beyond hospital discharge. 7:00 AM, Wed January 24, 2018 Opioid Agonists, Partial Agonists, Antagonists: Oh My! http://www.pharmacytimes.com/contributor/jeffrey-fudin/2018/01/opioid-agonists-partial-agonists-antagonists-oh-my A look at the different receptor bindings that affect analgesic effect. 8:00 AM, Sat January 6, 2018 Digital Pills Track Patient Dosing and Combat Opioid Addiction http://www.pharmacytimes.com/contributor/alex-barker-pharmd/2018/01/digital-pills-track-patient-dosing-and-combat-opioid-addiction Those familiar with the technology hope that the concept will develop enough that it can be integrated into daily life, as with an Apple Watch or a smartphone. 10:08 PM, Tue January 2, 2018 Sublocade for Opioid Use Disorder: What Pharmacists Should Know http://www.pharmacytimes.com/contributor/timothy-o-shea/2018/01/sublocade-for-opioid-use-disorder-what-pharmacists-should-know This article highlights several key therapeutics areas with Sublocade that every pharmacist should know. 11:01 PM, Mon January 1, 2018 Appropriate Gabapentin Dosing for Neuropathic Pain http://www.pharmacytimes.com/contributor/jeffrey-fudin/2017/12/appropriate-gabapentin-dosing-for-neuropathic-pain The established therapeutic dosing for gabapentin in neuropathic pain is 1800-3600 mg/day in 3 divided doses in patients with normal renal function. 10:09 PM, Tue December 19, 2017 Fosfomycin Use http://www.pharmacytimes.com/publications/health-system-edition/2017/November2017/fosfomycin-use Fosfomycin (Monurol) is an antibiotic that uses a unique mechanism of action to establish its bactericidal activity. 5:00 PM, Thu November 30, 2017